Bioprocessing

INFORS HT Launches Multifors 3 Bioreactor for Bioprocessing
Management & Regulatory INFORS HT Launches Multifors 3 Bioreactor for Bioprocessing

The Multifors 3 platform revolutionizes documentation by retaining hardware setups and cascade configurations as part of its core reproducibility strategy. This innovative approach to bench-scale bioprocessing arrives at a time when the pharmaceutical industry faces immense pressure to accelerate

Can JIBEs Revolutionize Synthetic Tissue Engineering?
Biotech & Bioprocessing Can JIBEs Revolutionize Synthetic Tissue Engineering?

The ability to produce deciliter-scale volumes of organized synthetic tissue within minutes represents a major breakthrough in materials science scalability. This advancement is driven by the development of Jammed Interconnected Bilayer Emulsions, commonly known as JIBEs, which mark a significant

Specialty Silicon Drives the Future of Biomanufacturing
Tech & Innovation Specialty Silicon Drives the Future of Biomanufacturing

Technology suppliers are currently focused on removing technical burdens to allow smaller biotech firms to access high-level efficiency and reproducibility. The biomanufacturing industry stands at a critical juncture where the simple accumulation of biological data no longer provides a competitive

Engineered Marine Bacteria Accelerate Carbon Dioxide Removal
Management & Regulatory Engineered Marine Bacteria Accelerate Carbon Dioxide Removal

Scaling up carbon removal requires a transparent monitoring framework, which is provided by the predictable stoichiometric ratios of mineral-based alkalinity generation. As the world moves through 2026, the urgency of the climate crisis has shifted the global conversation from simple emissions

How Can Stem Cells Rebuild the Human Intestine?
Biotech & Bioprocessing How Can Stem Cells Rebuild the Human Intestine?

Mapping the adult human intestine through spatial atlases is essential for bridging the biological gap between mouse models and human clinical applications. The human intestine remains one of the most biologically active environments in the body, defined by a relentless and necessary cycle of

Bora Biologics and Q Sera Partner to Scale RAPClot Production
Management & Regulatory Bora Biologics and Q Sera Partner to Scale RAPClot Production

Bora Biologics has executed over 200 cGMP batches to date, including more than 60 batches dedicated specifically to commercial supply programs. This extensive experience addresses a critical challenge in modern medicine: the need for reliable, high-speed diagnostic tools that can keep pace with an

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later